.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Accenture
US Army
Citi
Fuji
AstraZeneca
Baxter
Cantor Fitzgerald
Colorcon
Healthtrust

Generated: September 20, 2017

DrugPatentWatch Database Preview

ATHROMBIN Drug Profile

« Back to Dashboard

What is the patent landscape for Athrombin, and when can generic versions of Athrombin launch?

Athrombin is a drug marketed by Pharm Res Assoc and is included in one NDA.

The generic ingredient in ATHROMBIN is warfarin potassium. There are twenty-two drug master file entries for this compound. Additional details are available on the warfarin potassium profile page.

Summary for Tradename: ATHROMBIN

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list149
Patent Applications: see list4,069
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ATHROMBIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharm Res Assoc
ATHROMBIN
warfarin sodium
TABLET;ORAL011771-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN
warfarin sodium
TABLET;ORAL011771-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN
warfarin sodium
TABLET;ORAL011771-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharm Res Assoc
ATHROMBIN-K
warfarin potassium
TABLET;ORAL011771-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Harvard Business School
Federal Trade Commission
Cerilliant
Cipla
Covington
Johnson and Johnson
Healthtrust
Novartis
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot